News & Updates
Filter by Specialty:

Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Pneumococcal colonization rate lower in children with persistent asthma
05 Nov 2024
byStephen Padilla
Children with persistent asthma are less likely to be colonized with S. pneumoniae than those without asthma when seeking care for respiratory symptoms, reports a study.